AHA Scientific Sessions 2025 Abstract

A transformative LDL cholesterol–lowering in vivo CRISPR gene editing medicine that functionally upregulates LDLR in mice and non-human primates

By Judith A. Newmark, Paul J. Wrighton, Salvatore Iovino, Linda C. Burkly

Experiments in animalsInterventions

The paper

Editas Medicine (United States)

AHA Scientific Sessions 2025 Abstract, 3 Nov 2025

Presented at AHA Scientific Sessions 2025, abstract 4364195

doi.org/10.1161/circ.152.suppl_3.4364195

Nature Communications2 Oct 2026
Base editing of the lamin farnesylation motif rescues progeria phenotypes in organoids